Home › Ependymoma › District of Columbia
Ependymoma clinical trials in District of Columbia
3 studies for Ependymoma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's National Hospital, Washington D.C.
Recruiting
12 Months – 39 Years · All sexes · Updated Aug 11, 2026 · NCT05057702Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
- Children's National Hospital, Washington D.C.
RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Jun 17, 2026 · NCT06193759ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Children's National Hospital, Washington D.C.
RecruitingPhase 1
Ages 2 to 21 · All sexes · Updated Jun 11, 2026 · NCT04732065From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.